✦ LIBER ✦

Risk of Mortality, Fatal Infection, and Fatal Malignancy Related to Use of Anti-Tumor Necrosis Factor-α Biologics by Rheumatoid Arthritis Patients

✍ Scribed by Veena Thyagarajan; Heather Norman; Kimberly A. Alexander; Pavel Napalkov; Cheryl Enger

Book ID: 118033031
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 871 KB
Volume: 42
Category: Article
ISSN: 0049-0172
DOI: 10.1016/j.semarthrit.2012.05.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti–tumor necrosis factor α therapy and

Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis

✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif

Erratum to “Risk of significant infectio

Erratum to “Risk of significant infection in rheumatoid arthritis patients switching anti-tumor necrosis factor-α-drugs” [Semin. Arthritis Rheum. 42(2) (2011) 119–126]

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Use of a disease risk score to compare s

Use of a disease risk score to compare serious infections associated with anti–tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

✍ Jeffrey R. Curtis; Fenglong Xie; Lang Chen; Paul Muntner; Carlos G. Grijalva; Cl 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 257 KB

Drug-specific and time-dependent risks o

Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor α antagonists

✍ Jeffrey R. Curtis; Juan Xi; Nivedita Patkar; Aiyuan Xie; Kenneth G. Saag; Caroly 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Reduction in the incidence of myocardial

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register

✍ W. G. Dixon; K. D. Watson; M. Lunt; K. L. Hyrich; A. J. Silman; D. P. M. Symmons 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

An alternative, autonomic rationale for

An alternative, autonomic rationale for decreased risk of myocardial infarction in patients with rheumatoid arthritis responsive to anti–tumor necrosis factor therapy: Comment on the article by Dixon et al

✍ Andrew J. Holman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views